Non-personal research support services for diarrheal disease research (DDR) covering the areas of antigen discovery/purification, molecular engineering, immunological research, in vitro and in vivo…
Ended Awarded Last action
- Contract number
- HT942525FE069
- Awardee
-
Goldbelt C6, LLC UEI LSY9B62DKAC8
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $1,363,382
Award facts
- Contract value 15% obligated
-
- $3,449,006.50 Current, with exercised options
- $8,947,007.19 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Silver Spring, MD 20910, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $260,000 | |
| Other Administrative Action | $29,913 | |
| Other Administrative Action | $0 | |
| Original award | $1,073,469 |
About this award
The Defense Health Agency issued a delivery order to Goldbelt C6, LLC on September 29, 2025, under the Omnibus IV Military Medical Research and Development indefinite delivery contract for non-personal research support services covering diarrheal disease research, including antigen discovery and purification, molecular engineering, immunological research, and in vitro and in vivo services. The order carries a ceiling value of $8,947,007.19 and is priced on a cost-plus-fixed-fee basis.
Goldbelt C6 is an Alaska Native Corporation and 8(a) certified small disadvantaged business. Place of performance is Silver Spring, Maryland. The order runs through September 28, 2030 and is issued under the total small business set-aside.
Description
Non-personal research support services for diarrheal disease research (DDR) covering the areas of antigen discovery/purification, molecular engineering, immunological research, in vitro and in vivo services.
Quick answers
Who was awarded contract HT942525FE069?
HT942525FE069 was awarded to Goldbelt C6, LLC by Defense Health Agency (Department of Defense) on September 29, 2025.
How much is contract HT942525FE069 worth?
The government has obligated $1,363,382 on HT942525FE069. Its current value, with exercised options, is $3,449,007. Its potential value, with all options, is $8,947,007.
Is contract HT942525FE069 an order under another contract?
Yes. HT942525FE069 is a delivery order under HT001122D0021, an indefinite delivery contract, on Omnibus IV Military Medical Research And Development (OMNIBUS IV).
Was contract HT942525FE069 competed?
The extent of competition for HT942525FE069 was full and open competition. The government received 2 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award